In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • The Pipeline Embolization Device: Learning Curve and Predictors of Complications and Aneurysm Obliteration.

    Final Number:
    1074

    Authors:
    Nohra Chalouhi MD; Stavropoula I. Tjoumakaris MD; L. Fernando Gonzalez MD; Aaron S. Dumont MD; Ciro G. Randazzo MD; Robert M. Starke MD MSc; David M. Hasan MD; Rohan Chitale MD; Saurabh Singhal; Lea A Moukarzel; Robert H. Rosenwasser MD, FACS, FAHA; Pascal Jabbour MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: The pipeline embolization device (PED) has emerged as a promising treatment for intracranial aneurysms. The purpose of this study was to assess the safety and efficacy of the PED, analyze the effect of operator’s experience on the complication rate, and identify predictors of complications and obliteration.

    Methods: A total of 109 patients with 120 aneurysms were treated with PED at our institution. The patient population was divided into 3 consecutive equal groups to assess whether overall and major complication rates have decreased over time: Group I, patient 1-37; Group II, patient 38-73; and Group III, patient 74-109.

    Results: The number of PEDs used was 1.40 per aneurysm. Symptomatic and major procedure-related complications occurred in 11% and 3.7% of patients, respectively. The rate of complications decreased from 16.2% in group I to 5.6% in group III and the rate of major complications dramatically fell from 10.8% in group I to 0% in groups II and III (p<.05). Procedure time significantly decreased over time (p=0.04). In multivariate analysis, previously treated aneurysms were predictive of procedural complications (p=.02). At the latest follow-up, 65.8% of aneurysms were completely occluded, 9.6% were near-completely occluded, and 24.6% were incompletely occluded. In multivariate analysis, fusiform aneurysms (p=.05) and shorter angiographic follow-up (p=.03) were negative predictors of aneurysm obliteration.

    Conclusions: PED therapy has a favorable safety-efficacy profile. The risk of complications appears to decrease dramatically with physician experience supporting the existence of a learning curve. Patients with previously treated aneurysms have higher complication rates whereas fusiform aneurysms achieve lower obliteration rates.

    Patient Care: This is the first study to date to assess the existence of a learning curve during PED treatment of intracranial aneurysms. Neurosurgeons should be aware of the influence of the learning curve on the procedure-related complication rate. Therefore, extensive formal training could reduce early complications. Recognition of the steep learning curve may also be important in considering referrals for PED therapy.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Discuss the effect of the learning curve on procedural safety with PED therapy. 2) Discuss predictors of morbidity and aneurysm obliteration with the PED. 3) Optimize the treatment of patients undergoing PED therapy.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy